Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown on the page, replacing v3.6.2, indicating an internal version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-05T11:01:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.0 to v3.6.2, indicating a newer page version has been published.
    Difference
    0.0%
    Check dated 2026-06-28T08:17:34.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Adds recruitment-status notice and new user guidance sections, and updates the Intervention/Treatment label and revision version, while removing the older revision label.
    Difference
    0.1%
    Check dated 2026-06-13T17:50:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page template.
    Difference
    0.0%
    Check dated 2026-06-06T14:19:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, and the old AstraZeneca study locator contact block was removed.
    Difference
    0.0%
    Check dated 2026-05-15T23:59:17.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page’s footer has updated the ClinicalTrials.gov interface revision/version from v3.5.2 to v3.5.3. This reflects a platform update rather than a change to the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-24T16:52:39.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.